BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33960047)

  • 1. Effects of dupilumab treatment on patch test reactions: A retrospective evaluation.
    de Wijs LEM; van der Waa JD; Nijsten T; Silverberg JI; Kunkeler ACM; Hijnen DJ
    Clin Exp Allergy; 2021 Jul; 51(7):959-967. PubMed ID: 33960047
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: A retrospective chart review.
    Raffi J; Suresh R; Botto N; Murase JE
    J Am Acad Dermatol; 2020 Jan; 82(1):132-138. PubMed ID: 31562940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic contact dermatitis to Compositae: A possible cause of dupilumab-associated facial and neck dermatitis in atopic dermatitis patients?
    Napolitano M; Fabbrocini G; Patruno C
    Contact Dermatitis; 2021 Oct; 85(4):473-474. PubMed ID: 33988858
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of Residual Facial Dermatitis during Dupilumab Therapy: A Retrospective Chart Review to Delineate the Potential Role of Expanded Series Patch Testing.
    Ashbaugh AG; Murase EM; Raffi J; Botto N; Murase JE
    Dermatitis; 2022 Jan-Feb 01; 33(1):51-61. PubMed ID: 35029349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dupilumab for allergic contact dermatitis and implications for patch testing: Irreconcilable differences.
    Shah P; Milam EC; Lo Sicco KI; Cohen DE
    J Am Acad Dermatol; 2020 Sep; 83(3):e215-e216. PubMed ID: 32417419
    [No Abstract]   [Full Text] [Related]  

  • 6. Patch Testing in a Patient on Dupilumab.
    Hoot JW; Douglas JD; Falo LD
    Dermatitis; 2018; 29(3):164. PubMed ID: 29570490
    [No Abstract]   [Full Text] [Related]  

  • 7. Variable impact of dupilumab on patch testing results and allergic contact dermatitis in adults with atopic dermatitis.
    Stout M; Silverberg JI
    J Am Acad Dermatol; 2019 Jul; 81(1):157-162. PubMed ID: 30885752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking type 2 inflammation by dupilumab does not control classic (type 1-driven) allergic contact dermatitis in chronic hand eczema.
    Crepy MN; Nosbaum A; Bensefa-Colas L
    Contact Dermatitis; 2019 Aug; 81(2):145-147. PubMed ID: 30851059
    [No Abstract]   [Full Text] [Related]  

  • 9. Two differing presentations of periocular dermatitis as a side effect of dupilumab for atopic dermatitis.
    Yamane MLM; Belsito DV; Glass LRD
    Orbit; 2019 Oct; 38(5):390-394. PubMed ID: 30628518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous delayed-type hypersensitivity in patients with atopic dermatitis.
    Malajian D; Belsito DV
    J Am Acad Dermatol; 2013 Aug; 69(2):232-7. PubMed ID: 23583066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous sodium lauryl sulphate testing improves the diagnostic validity of allergic patch tests. Results from a prospective multicentre study of the German Contact Dermatitis Research Group (Deutsche Kontaktallergie-Gruppe, DKG).
    Löffler H; Becker D; Brasch J; Geier J;
    Br J Dermatol; 2005 Apr; 152(4):709-19. PubMed ID: 15840103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recall dermatitis at patch test sites in an atopic dermatitis patient treated with dupilumab.
    Collantes-Rodríguez C; Jiménez-Gallo D; Ossorio-García L; Villegas-Romero I; Linares-Barrios M
    Contact Dermatitis; 2019 Jan; 80(1):69-70. PubMed ID: 30334260
    [No Abstract]   [Full Text] [Related]  

  • 13. Expanded Series and Personalized Patch Tests for Children: A Retrospective Cohort Study.
    Collis RW; Morris GM; Sheinbein DM; Coughlin CC
    Dermatitis; 2020; 31(2):144-146. PubMed ID: 31441780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patch Testing and Allergen-Specific Inhibition in a Patient Taking Dupilumab.
    Raffi J; Botto N
    JAMA Dermatol; 2019 Jan; 155(1):120-121. PubMed ID: 30484816
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of dupilumab on allergic contact dermatitis and patch testing.
    Jo CE; Mufti A; Sachdeva M; Pratt M; Yeung J
    J Am Acad Dermatol; 2021 Jun; 84(6):1772-1776. PubMed ID: 33617912
    [No Abstract]   [Full Text] [Related]  

  • 16. Allergic contact dermatitis from Laurus nobilis oil induced by massage.
    Adişen E; Onder M
    Contact Dermatitis; 2007 Jun; 56(6):360-1. PubMed ID: 17577382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of patch-tests from Santa Casa de Belo Horizonte Dermatology Clinic, Belo Horizonte, Brazil, from 2003 to 2010.
    Rodrigues DF; Neves DR; Pinto JM; Alves MF; Fulgêncio AC
    An Bras Dermatol; 2012; 87(5):800-3. PubMed ID: 23044584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pattern of contact sensitization in patients with and without atopic dermatitis in a hospital-based clinical database.
    Clemmensen KK; Thomsen SF; Jemec GB; Agner T
    Contact Dermatitis; 2014 Aug; 71(2):75-81. PubMed ID: 24697272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact Allergy in Children with Atopic Dermatitis: A Retrospective Study.
    Romita P; Foti C; Stingeni L; Hansel K; Magrone T; Belsito DV; Bonamonte D
    Endocr Metab Immune Disord Drug Targets; 2019; 19(7):1083-1087. PubMed ID: 30747086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of patch testing children with atopic dermatitis.
    Vender RB
    Skin Therapy Lett; 2002 Jun; 7(6):4-6. PubMed ID: 12223977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.